旨日清缓释茶提醒小心脂肪肝,不要被忽悠了(The purpose of sustained release tea reminder be careful not to be fooled by the fatty liver.).docVIP

旨日清缓释茶提醒小心脂肪肝,不要被忽悠了(The purpose of sustained release tea reminder be careful not to be fooled by the fatty liver.).doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
旨日清缓释茶提醒小心脂肪肝,不要被忽悠了(The purpose of sustained release tea reminder be careful not to be fooled by the fatty liver.)

旨日清缓释茶提醒小心脂肪肝,不要被忽悠了(The purpose of sustained release tea reminder be careful not to be fooled by the fatty liver.) Modern society, peoples living standards continue to improve, food structure, lifestyle changes are also quietly. Excessive drinking, food and other unhealthy lifestyle have fatty liver the diseases in our country the incidence rate increased significantly, and the trend was younger, among them, 30 - 40 year old male accounted for all patients with fatty liver 1/4. Now, fatty liver has become the time of common diseases harmful to human health, fatty liver disease is also more and more people are familiar with, but a lot of fatty liver patients did not have a comprehensive understanding for fatty liver, there are many problems of understanding. The purpose of the tea will release you one by one analysis of misunderstanding on fatty liver. Misunderstanding 1: the treatment of fatty liver mainly depends on lipid-lowering drugs Despite the close relationship between hyperlipidemia and fatty liver, but lipid-lowering drugs to promote liver fat metabolism, accelerate the transport of fat in the liver, can only play a supporting role; and tolerance of fatty liver of hypolipidemic drugs decreased, improper use can also increase the burden of gastrointestinal and liver, resulting in adverse drug reactions. Anti lipid drugs such as n-butyl chloride, benzyl Zabete, fenofibrate, Giffey Bate and niacin can have different effects on liver function, and they are not suitable for patients with fatty liver. Therefore, fatty liver is not associated with hyperlipidemia, it is not recommended to take lipid-lowering drugs. Fatty liver patients with hyperlipidemia need to take lipid-lowering drugs. They also need proper reduction and monitoring of liver function and liver protection drugs when necessary. Myth two: only fat people get fatty liver Fatty liver is not an independent disease, in addition to obesity, hyperlipidemia and nutrition, but also by alcoholism, diabetes

您可能关注的文档

文档评论(0)

jgx3536 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6111134150000003

1亿VIP精品文档

相关文档